The Division of Molecular Medicine and Gene Therapy is located at the Biomedical Center (BMC), Lund University, Sweden. Established as a joint venture between the Medical Faculty at Lund University and the Hematology Clinic at Lund University Hospital, our mission is to translate basic science to clinical applications.
Our research focuses on hematopoiesis, the continuous and dynamic process of blood cell formation. The laboratory consists of eight closely collaborating research groups that all share a common interest in investigating the properties of blood stem cells to eventually understand and treat hematological disorders.
Five of our researchers belong to the Hemato-Linné Excellence Linnaeus Research Environment funded by The Swedish Research Council and Lund University. Several of the groups are engaged in StemTherapy, a Strategic Research Area for Stem Cells and Regenerative Medicine that is also supported by The Swedish Research Council.
Professor Eva Hellström Lindberg from the Department of Medicine, Huddinge, Karolinska Insitutet, Stockholm, Sweden will be visiting Lund on October 22 - 23, 2015 in connection with Maria Dahl's thesis defense.
She will give a lecture entitled "Unravelling the genotype-phenotype relation in splice-factor SF3B1 mutated sideroblastic anemia" on Friday October 23 at 10:00 in the seminar room I1345.
Professor Juan Bueren from the Division of Hematopoietic Innovative Therapies, CIEMAT/ CIBERER, Madrid, Spain will be visiting Lund on October 22 - 23, 2015 in connection with Maria Dahl's thesis defense.
He will give a lecture entitled "Lentiviral-mediated gene therapy and gene editing in Fanconi anemia" on Thursday October 22 at 16:00 in the seminar room I1345.
Maria Dahl will defend her thesis entitled "Cell and gene therapy for blood disorders. Modeling of novel treatment strategies for Gaucher type 1 disease and Diamond-Blackfan anemia in mice" on October 23 at 13:00 in the Segerfalk Lecture Hall.
Faculty opponent: Professor Juan Bueren, Division of Hematopoietic Innovative Therapies, CIEMAT/ CIBERER, Madrid, Spain
Main supervisor: Professor Stefan Karlsson
Congratulations to Charlotta Böiers who was awarded the prestigious Marie Skłodowska Curie International Career Grant. The aim of the grant is to give young researchers the opportunity to develop early on in their careers, both within the framework of their own research and as future research leaders. The grant focuses on career development through international mobility. Charlotta will be spending two thirds of the grant period at UCL Cancer Institute in Professor Tariq Enver's research group, and one third at the Division of Molecular Medicine and Gene Therapy, Lund University.